Food News and Research

RSS

Democrats weary of health changes, mull new health bills, 'doc fix'

Democrats are feeling health care "fatigue" and are doubting that Congress will consider any more health-related legislation this year. "Measures in jeopardy include bills that would require more information on healthcare prices, empower federal regulators to sign off on premium increases and strip insurers of their exemption from anti-trust laws."

15 May 2010

BioMS reports consolidated net income of $6.5M for first-quarter 2010 compared to net loss of $3.8M in 2009

BioMS Medical Corp., today announced financial and operational results for the three months ended March 31, 2010.

15 May 2010

BioSante Pharmaceuticals first-quarter net loss increases to $10.5 million

BioSante Pharmaceuticals, Inc. today reported on its recent developments and financial results for the first quarter, and its cash balance as of March 31, 2010.

14 May 2010

Report underscores need for additional research on diagnosis and treatment of food allergy

A review published Wednesday in the Journal of the American Medical Association and reported in the New York Times underscores the need for additional research on the prevalence, diagnosis, and treatment of food allergy. One of the most important points suggested by the JAMA study as well as a New York Times article on the subject is that as many as 1 in 10 people may have food allergy.

14 May 2010

Nutrastar International's first-quarter 2010 revenues up 2.7%

Nutrastar International Inc., a leading nutraceutical company which produces and distributes Chinese Golden Grass and organic and specialty food products in China, today announced its financial results for the first quarter 2010.

14 May 2010

Hana Biosciences reports $5.5 million net loss for first-quarter 2010

Hana Biosciences Inc.,, a biopharmaceutical company focused on strengthening the foundation of cancer care, today reported financial results for the first quarter ended March 31, 2010, and provided a corporate update.

14 May 2010

FDA grants tentative approval for Impax Laboratories' generic Opana ER

Impax Laboratories, Inc. today confirmed that the U.S. Food and Drug Administration (FDA) has granted tentative approval of the Company's Abbreviated New Drug Application (ANDA) for generic version of Opana® ER (oxymorphone hydrochloride) 5, 7.5, 10, 15, 20, 30 and 40 mg tablets.

14 May 2010

IVAX Diagnostics first-quarter net revenues decline 1.4% to $4,655,000

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, reports its financial results for the quarter ended March 31, 2010.

14 May 2010

Leaving food out in the sun can put you at risk for food-borne illness

Leaving food out in the sun too long can put a damper on your summer picnic.

14 May 2010

Media Line/All Headline News examines agriculture investment gap in Middle East

"Arab countries need to invest some $144 billion in agriculture over the next 20 years to meet the food demands of the growing population, an Arab agricultural organization has said," the Media Line/All Headline News reports in a piece that examines the contributing factors to gaps in food security in the region.

14 May 2010

EPA continues to validate ToxCast screening tool by testing more than 100 drugs

The U.S. Environmental Protection Agency will continue validating its ToxCast screening tool by screening more than 100 drugs provided by Pfizer, GlaxoSmithKline, Sanofi-Aventis, and Merck. These drugs never entered the marketplace because they demonstrated different types and levels of toxicity when the pharmaceutical companies conducted the early stage clinical trials required by the Food and Drug Administration as part of the drug development process.

14 May 2010

U.N. Secretary-General discusses G8, G20 commitments during visit to Ottawa

On Wednesday, ahead of a meeting with Canadian Prime Minister Stephen Harper, U.N. Secretary-General Ban Ki-moon addressed several topics in a "speech warning that leaders of the G8 and G20 countries should not use global economic and financial difficulties as 'an excuse' to neglect previous pledges of billions of dollars for the world's poor - for doubling aid to Africa, food security, malaria and AIDS programs and maternal and child health care," Canwest News Service/Calgary Herald writes (O'Neill, 5/12).

14 May 2010

Inhibitex reports net loss of $4.8M for first-quarter 2010

Inhibitex, Inc. today announced its financial results for the first quarter ended March 31, 2010. The Company also announced that it has initiated a Phase I single ascending dose trial of INX-189, its lead HCV nucleotide polymerase inhibitor, in healthy volunteers under an Investigational New Drug application with the U.S. Food and Drug Administration.

14 May 2010

St. Jude Medical announces FDA clearance and CE Mark approval for EnSite Derexi module

St. Jude Medical, Inc., a global medical device company, today announced U.S. Food and Drug Administration (FDA) clearance, CE Mark approval and the launch of the EnSite Derexi™ module, which provides improved electrophysiology (EP) lab efficiency and workflow by enabling communication between the EnSite™ Velocity™ Cardiac Mapping System and the EP-Workmate™ Recording System.

14 May 2010

International study to test effectiveness of celecoxib in preventing growth of precancerous polyps

Rush University Medical Center is testing whether celecoxib, known by its brand name Celebrex, can help prevent the growth of precancerous polyps that form in the colon, rectum and small intestine of children with an inheritable genetic disease called familial adenomatous polyposis.

14 May 2010

Nationwide Children's Hospital offers new gastric sleeve surgical weight loss procedure

A new weight reduction surgical option is now available through the Center for Healthy Weight and Nutrition at Nationwide Children's Hospital. The newest surgical weight loss procedure offered by the Center is the "gastric sleeve," named as such because a large part of the stomach is removed and the remainder is closed to make a tube-like "sleeve."

14 May 2010

Sinovac Biotech's sales for first-quarter 2010 decrease 32% to $4.4M

Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month period ended March 31, 2010.

14 May 2010

Minnesota lawmakers debate budget, Medicaid expansion

More budget talks were expected Thursday as Minnesota's legislative session hurtled toward a midnight Sunday deadline with no deal on a $3 billion deficit. The Democratic-controlled Legislature defied another veto threat from Republican Gov. Tim Pawlenty late Wednesday and sent him a health and welfare package he opposes.

14 May 2010

Fibrocell Science commences histology study of azficel-T for treatment of nasolabial fold wrinkles

Fibrocell Science, Inc., a biotechnology company focused on the development of autologous cell therapies for aesthetic, medical and scientific applications, announced the initiation of a small histology study (IT-H-001) of azficel-T, an autologous cell therapy currently under review by the U.S. Food and Drug Administration (FDA) for the treatment of moderate to severe nasolabial fold wrinkles.

14 May 2010

Federal officials say crackdown on Medicare fraud recovers $2.5 billion

The Associated Press: "The government says it recovered $2.5 billion in overpayments for the Medicare trust fund last year as the Obama administration focused attention on fraud enforcement efforts in the health care industry. Investigators have new tools this year to help crack down on health care fraud, with the Justice Department and the Health and Human Services Department working cooperatively to police companies.

14 May 2010